The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An international phase 3 randomized, placebo-controlled study of CC-486 (oral azacitidine) maintenance therapy in patients with acute myeloid leukemia (AML) in complete remission (CR): the Quazar AML maintenance trial.
 
Gail J. Roboz
Consulting or Advisory Role - Celgene
 
Farhad Ravandi
Research Funding - Celgene
 
Dominik Selleslag
Honoraria - Celgene
Research Funding - Celgene
 
Pau Montesinos
No Relationships to Disclose
 
Andrew Wei
Consulting or Advisory Role - Celgene
Research Funding - Celgene
 
Kimmo Porkka
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; Novartis
 
Antonio Almeida
Honoraria - Celgene
Consulting or Advisory Role - Celgene
 
Michael R. Savona
Honoraria - Celgene; GlaxoSmithKline; Janssen; Novartis
Research Funding - Celgene
 
Sanjay Ram Mohan
No Relationships to Disclose
 
Jose F Falantes
Honoraria - Celgene
 
Maria Teresa Voso
Honoraria - Celgene
Research Funding - Celgene
 
Keshava Kumar
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Frederic Camus
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Ignazia La Torre
Employment - Celgene
 
Hagop Kantarjian
No Relationships to Disclose
 
Barry Skikne
Employment - Celgene
Stock and Other Ownership Interests - Celgene